Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of ...

Among the 55 novel drugs that crossed the regulatory finish line last year were notable new mechanisms of action, coming ...

Preliminary fourth quarter neffy® net product revenue of approximately $6.5 million Preliminary cash, cash equivalents and ...

There are many unpleasant aspects of the cold winter season, and chief among them is the havoc it can wreak on sinuses. Even ...

Dr. Scott Manthei of the Nevada Ear and Sinus Institute has been advising patients against taking drugs like Sudafed for ...

Understanding a child’s asthma type can help target treatment, but pinpointing it has relied on an invasive procedure that ...

A more sinister trend may be behind the humble nasal strip becoming an unlikely must-have fashion accessory for Gen Z.

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

A more sinister trend may be behind the humble nasal strip becoming an unlikely must-have fashion accessory for Gen Z.

Blowing your nose too forcefully could damage your nasal passages or push mucus back into your sinuses, increasing congestion.

“With submission in Canada and the UK, ARS Pharma now has approval or has filed for approval in jurisdictions comprising more ...

Canada and United Kingdom represent two of the largest markets within the ALK portfolio with plans to expand filings of neffy (epinephrine nasal ...